8-K: Lifecore Biomedical Secures $8 Million in Liquidity, Assigns Subsidiary Assets for Creditor Benefit
Liquidity Update
Lifecore Biomedical announced it has secured approximately $8 million in incremental liquidity through lender agreements and is assigning assets of a subsidiary for the benefit of creditors.
Summary
- Lifecore Biomedical has obtained approximately $8 million in additional liquidity through various amendments with lenders.
- This includes a $5.5 million prepayment from a lender as an advance on future purchases and approximately $2.5 million in incremental revolving loan capacity.
- The company's total debt was $178.9 million and cash was $3.0 million as of April 21, 2024.
- Pro forma, giving effect to the new liquidity, cash would have been $11.0 million as of April 21, 2024.
- Lifecore is also assigning the assets of its subsidiary, Curation Foods, Inc., for the benefit of creditors to finalize its winding down.
- The company has amended its 2024 Annual Incentive Plan to pay executive bonuses in fully vested shares of common stock.
- The company is working with a new independent auditor, BDO, to become current on its public filings.
Sentiment
Score: 4
Explanation: While the company has secured additional liquidity, the assignment of a subsidiary for the benefit of creditors and the increased interest rates suggest underlying financial challenges. The sentiment is cautiously negative.
Positives
- The company has successfully secured $8 million in incremental liquidity, improving its financial position.
- The prepayment from a lender provides a cash injection and secures future business.
- The FILO amendment provides additional borrowing capacity without increasing the overall revolver commitment.
- The company is taking steps to finalize the winding down of its subsidiary, Curation Foods, Inc.
- The company is working to become current on its public filings with a new auditor.
Negatives
- The FILO amendment increases the interest rate, leading to an expected increase in annual cash interest expense by approximately $44,000.
- The assignment of Curation Foods, Inc. assets indicates the subsidiary is not viable and is being liquidated.
- The maximum capacity of permitted borrowings under the FILO Amendment will be reduced on a monthly basis commencing October 1, 2025.
Risks
- The company's ability to effectuate the assignment of assets on the contemplated terms is not guaranteed.
- Claims or proceedings may arise that could interfere with the assignment.
- The company's ability to operate its business consistent with its business plan is subject to risks.
- Potential future changes in strategy or economic factors could impact the company.
- The company's ability to become current with its SEC filings and regain compliance with Nasdaq listing standards is not guaranteed.
- The company faces risks related to competition, inflation, and market cycles in the CDMO market.
Future Outlook
The company believes the incremental liquidity improvements will provide additional financial resources to continue to achieve its business objectives and is working to become current on its public filings.
Management Comments
- James G. Hall, President and Chief Executive Officer of Lifecore, commented, 'We believe these incremental liquidity improvements will provide Lifecore with additional financial resources to continue to achieve its business objectives.'
- The company is excited about working with its new independent auditor, BDO, as it seeks to get current on its public filings as promptly as possible.
Industry Context
The announcement reflects the challenges faced by some CDMOs in managing debt and liquidity, particularly in a fluctuating economic environment. The company's actions to secure additional liquidity and streamline operations are common strategies in the industry.
Comparison to Industry Standards
- The $8 million in incremental liquidity is a relatively small amount compared to the overall debt of $178.9 million, suggesting the company is still facing financial challenges.
- The assignment of a subsidiary for the benefit of creditors is a significant step, indicating the subsidiary was likely underperforming and not viable.
- The increase in interest rates on the FILO amendment is in line with current market conditions, but it adds to the company's financial burden.
- Other CDMOs such as Catalent and Lonza have also been facing financial pressures, but their scale and diversification are generally much larger than Lifecore's.
Stakeholder Impact
- Shareholders may be concerned about the financial health of the company and the assignment of a subsidiary.
- Creditors of Curation Foods, Inc. will be impacted by the assignment of assets for their benefit.
- Employees may be affected by the winding down of Curation Foods, Inc.
Next Steps
- The assignee will seek to monetize any remaining assets of Curation Foods, Inc., and settle any remaining liabilities.
- The company will work with its new auditor, BDO, to become current on its public filings.
- The company will continue to operate its business and seek to achieve its business objectives.
Key Dates
| Date | Description |
|---|---|
| May 1, 2024 | The Compensation Committee and the Board approved an amendment to the 2024 Annual Incentive Plan. |
| May 2, 2024 | The company entered into an amendment related to its contract manufacturing agreement with its term lender. |
| May 10, 2024 | The company entered into the Seventh Amendment to the ABL Loan Agreement with its ABL lender. |
| May 15, 2024 | The company entered into an assignment for the benefits of creditors related to Curation Foods, Inc. |
| May 16, 2024 | The company issued a press release related to its incremental liquidity initiatives. |
| October 1, 2025 | The maximum capacity of permitted borrowings pursuant to the FILO Amendment will be reduced on a monthly basis. |
Keywords
liquidity, CDMO, debt, lender, assignment, Curation Foods, revolving loan, FILO, interest rate, financial filings
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.